Poland – Antineoplastic agents – Delivery of the medicinal product Pembrolizumab settled under the B.6 drug program.
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the order is the supply of the medicinal product Pembrolizumab, concentrate for solution for infusion, 25 mg/ml; pack x 1 vial. a 4 ml, pack 4090.